Actively Recruiting
Acoustic Stimulation, Sleep, and Cognitive-Emotional Processes in Young Adults With Anxiety and Depression Symptoms
Led by Michelle Stepan · Updated on 2025-09-18
40
Participants Needed
1
Research Sites
148 weeks
Total Duration
On this page
Sponsors
M
Michelle Stepan
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
In this study, the investigators will recruit young adults (ages 18-25 years) with elevated anxiety/depression symptoms and sleep disturbance. Participants will complete two overnights in a sleep lab. During one of the overnights, slow-wave activity will be enhanced by delivering sub-arousal auditory tones during slow-wave sleep using a headband device (Philips SmartSleep or Dreem 2). During the other overnight, tones will not be administered. Cognitive and emotional processes will be evaluated using behavioral task performance, self-report, and functional magnetic resonance imaging (fMRI). After the second overnight, participants will take the headband device home and wear it every night for approximately 2 weeks. For half of the participants, the headband will play tones every night and, for the other half, the headband will not play tones. Participants will then return for a final testing visit in which cognitive and emotional processes and anxiety/depression symptoms will be assessed using behavioral task performance and self-report.
CONDITIONS
Official Title
Acoustic Stimulation, Sleep, and Cognitive-Emotional Processes in Young Adults With Anxiety and Depression Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 25 years, with equal numbers of men and women included
- Normal hearing
- Elevated anxiety or depression symptoms as measured by PROMIS scales with T-scores ≥ 60
- Elevated sleep disturbance with PROMIS sleep disturbance T-score ≥ 55
You will not qualify if you...
- Severe chronic or psychiatric conditions such as psychosis, bipolar disorder, developmental disorders, or substance use disorder
- Current use of psychotropic or sleep-affecting medications including antidepressants, antipsychotics, steroids, or stimulants
- Substance abuse
- Consuming more than 14 alcoholic drinks per week
- Consuming more than 400 mg of caffeine daily
- Drug or alcohol use within 48 hours before in-lab overnight sessions
- Severe insomnia (Insomnia Severity Index score > 21) or sleep apnea risk (STOP-Bang score ≥ 3)
- Extreme bedtimes (before 10:00pm or after 1:00am) or wake times (before 6:00am or after 10:00am)
- Average sleep duration less than 5 hours or more than 9 hours
- Uncorrected vision problems
- Claustrophobia
- Metal in the body
- Body Mass Index (BMI) greater than 40
- Pregnancy
- Left-handedness
- Formal vocal training or good/very good singing ability
- Does not own a smartphone or tablet
- Unable or unwilling to complete study procedures
- Hairstyles that prevent scalp access for electrode placement (e.g., weave)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
M
Michelle E Stepan, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here